Year |
Citation |
Score |
2016 |
Neumann PJ, Thorat T, Zhong Y, Anderson J, Farquhar M, Salem M, Sandberg E, Saret CJ, Wilkinson C, Cohen JT. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. Plos One. 11: e0168512. PMID 28005986 DOI: 10.1371/Journal.Pone.0168512 |
0.466 |
|
2015 |
Sandberg E, O'Donnell TF, Chambers JD, Rane P, Suarez L, Iafrati MD. RR19. A Cost-Effective Analysis of Current Strategies for Managing Venous Leg Ulcers Journal of Vascular Surgery. 61. DOI: 10.1016/J.Jvs.2015.04.374 |
0.368 |
|
2003 |
McMahon PM, Araki SS, Sandberg EA, Neumann PJ, Gazelle GS. Cost-effectiveness of PET in the diagnosis of Alzheimer disease. Radiology. 228: 515-22. PMID 12802006 DOI: 10.1148/Radiol.2282020915 |
0.353 |
|
2001 |
Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK. Modeling for health care and other policy decisions: uses, roles, and validity. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 4: 348-61. PMID 11705125 DOI: 10.1046/J.1524-4733.2001.45061.X |
0.408 |
|
2001 |
Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. An off-the-shelf help list: A comprehensive catalog of preference scores from published cost-utility analyses Medical Decision Making. 21: 288-294. PMID 11475385 DOI: 10.1177/0272989X0102100404 |
0.397 |
|
2000 |
Chapman RH, Stone PW, Sandberg EA, Bell C, Neumann PJ. A comprehensive league table of cost-utility ratios and a sub-table of 'Panel-worthy' studies Medical Decision Making. 20: 451-467. PMID 11059478 DOI: 10.1177/0272989X0002000409 |
0.489 |
|
2000 |
Neumann PJ, Sandberg EA, Araki SS, Kuntz KM, Feeny D, Weinstein MC. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 20: 413-22. PMID 11059474 DOI: 10.1177/0272989X0002000405 |
0.461 |
|
2000 |
Earle CC, Chapman RH, Baker CS, Bell CM, Stone PW, Sandberg EA, Neumann PJ. Systematic overview of cost-utility assessments in oncology Journal of Clinical Oncology. 18: 3302-3317. PMID 10986064 DOI: 10.1200/Jco.2000.18.18.3302 |
0.457 |
|
2000 |
Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997 Annals of Internal Medicine. 132: 964-972. PMID 10858180 DOI: 10.7326/0003-4819-132-12-200006200-00007 |
0.47 |
|
2000 |
Stone PW, Chapman RH, Sandberg EA, Liljas B, Neumann PJ. Measuring costs in cost-utility analyses: Variations in the literature International Journal of Technology Assessment in Health Care. 16: 111-124. PMID 10815358 DOI: 10.1017/S0266462300161100 |
0.448 |
|
2000 |
Neumann PJ, Sandberg EA, Bell CM, Stone PW, Chapman RH. Are pharmaceuticals cost-effective? A review of the evidence Health Affairs. 19: 92-109. PMID 10718025 DOI: 10.1377/Hlthaff.19.2.92 |
0.404 |
|
1999 |
Neumann P, Stone P, Chapman R, Sandberg E. PPR7: A FORMAL AUDIT OF 228 PUBLISHED COST-UTILITY ANALYSES Value in Health. 2: 223. DOI: 10.1016/S1098-3015(11)71068-3 |
0.44 |
|
Show low-probability matches. |